Texas A&M Football

The Loochador Podcast: CFP is officially coming to Kyle Field

Kyle Field will officially host a College Football Playoff first-round game as the Fightin' Texas Aggies will square off with Miami on Dec. 20. On this edition of the Loochador Podcast, Billy Liucci and David Nuño share their thoughts on Texas A&M's seeding, possible path to the title and more.
The Loochador Podcast
By Billy Liucci
December 7, 2025
17k Views
Discuss
Story Poster
Free Preview
Watch the full version by becoming a Premium subscriber.
Try Premium for $1
No Thanks
Trial available for new subscribers only.
To watch the full version of this video feature, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Tags
Mike Elko David Nuño R.C. Slocum Kirby Smart Nick Saban Greg Sankey College Football Playoff Jimbo Fisher Mario Cristobal College Football Playoff rankings The Loochador Podcast Mike Denbrock
Show All
Dylan Stewart Jeremiyah Love Loochador Rueben Bain Jr. Texas A&M at Texas Texas A&M vs. Miami 2025 College Football Playoff Le'Veon Moss Marcel Reed KC Concepcion Mario Craver Football Texas A&M Texas Tech Oklahoma Texas Notre Dame Georgia Miami Ohio State Indiana Tulane BYU Alabama Ole Miss James Madison Oregon 2025
SPONSORED BY
Academy Sports + Outdoors
More Episodes
See All →
The Loochador Podcast: Spring practice starts on Friday
By Billy Liucci
The Loochador Podcast: Ags are dancin' in McMillan's first season
By Billy Liucci
The Loochador Podcast: Positional breakdown as portal prepares to close
By Billy Liucci
The Loochador Podcast: 2025 ends in a first-round exit at Kyle Field
By Billy Liucci
Discussion from...

The Loochador Podcast: CFP is officially coming to Kyle Field

7,930 Views | 0 Replies | Last: 4 mo ago by Liucci
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.